RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EFTR
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in eFFECTOR Therapeutics, Inc. stock price on Tuesday which ended trading at $0.180
(Updated on Jul 02, 2024)

Sell candidate since Apr 04, 2024 Loss -93.92% PDF

The eFFECTOR Therapeutics, Inc. stock price fell by -32.56% on the last day (Tuesday, 2nd Jul 2024) from $0.267 to $0.180. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 38.95% from a day low at $0.171 to a day high of $0.238. The price has fallen in 7 of the last 10 days and is down by -85.48% for this period. Volume has increased on the last day by 407 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $253.51 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EFTR Signals & Forecast

There are few to no technical positive signals at the moment. The eFFECTOR Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.268 and $1.31. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 30, 2024, and so far it has fallen -92.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). eFFECTOR Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for eFFECTOR Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0666 between high and low, or 38.95%. For the last week, the stock has had daily average volatility of 21.86%.

eFFECTOR Therapeutics, Inc. is oversold on RSI14 (8). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EFTR) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect eFFECTOR Therapeutics, Inc. to open at $0.196, and during the day (based on 14 day Average True Range), to move between $0.0055 and $0.355, which gives a possible trading interval of +/-$0.175 (+/-96.96%) up or down from last closing price. If eFFECTOR Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 193.91% move between the lowest and the highest trading price during the day.

Is eFFECTOR Therapeutics, Inc. stock A Buy?

eFFECTOR Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.114 Strong Sell Candidate Unchanged

Predicted Opening Price for eFFECTOR Therapeutics, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.196 ( 9.00%) $0.180

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EFTR

Fibonacci Support & Resistance Levels

Level Price
R3 0.263 46.00%
R2 0.237 31.87%
R1 0.222 23.13%
Price 0.180
S1 0.171 -5.13%
S2 0.155 -13.87%
S3 0.130 -28.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.180
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for eFFECTOR Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for eFFECTOR Therapeutics, Inc. is EFTR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell eFFECTOR Therapeutics, Inc. Stock?
eFFECTOR Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy eFFECTOR Therapeutics, Inc. Stock?
eFFECTOR Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy eFFECTOR Therapeutics, Inc. Stock.

What's the current price of eFFECTOR Therapeutics, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an eFFECTOR Therapeutics, Inc. (EFTR) share was $0.180.

What is the 52-week high and low for eFFECTOR Therapeutics, Inc. Stock?
The 52-week high for eFFECTOR Therapeutics, Inc. Stock is $17.75 and the 52-week low is $0.171.

What is the market capitalization of eFFECTOR Therapeutics, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of eFFECTOR Therapeutics, Inc. is 1.256M.

When is the next earnings date for eFFECTOR Therapeutics, Inc.?
The upcoming earnings date for eFFECTOR Therapeutics, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk... EFTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT